ORION BIOTECHNOLOGY SUCCESSFULLY COMPLETES PHASE I CLINICAL STUDY OF 0B-002H TOPICAL GEL FOR HIV PREVENTION
30. April 2020 13:21 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, April 30, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage pharmaceutical company focused on precision engineering small protein therapeutics, today...
Orion Biotechnology to Present at the BIO-Europe Spring 2020 Virtual Event
19. März 2020 10:07 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, March 19, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it will be presenting an update on the company’s...
Andreas Harstrick Joins Orion Biotechnology's Scientific Advisory Board
06. Februar 2020 10:07 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical-stage company, today announced the addition of Dr. Andreas Harstrick to its Scientific Advisory Board...
Orion Biotechnology Acquires Exclusive License to University of Geneva Novel Drug Discovery Platform
21. Januar 2020 09:20 ET
|
Orion Biotechnology Canada Ltd.
Ottawa, Canada, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a clinical stage biotechnology company, today announced that it has executed a definitive agreement with the...